# The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg

> **NCT01624207** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 376 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** generic formulation of atorvastatin (Atorva®)
- **DRUG:** branded formulation of atorvastatin (Lipitor®)

## Key facts

- **NCT ID:** NCT01624207
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-01
- **Final completion:** 2011-04
- **Target enrollment:** 376 (ACTUAL)
- **Last updated:** 2013-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01624207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01624207, "The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01624207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*